rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-2-2
|
pubmed:abstractText |
Combination therapy using ursodeoxycholic acid plus chenodeoxycholic acid has been advocated for dissolution of cholesterol gallstones because the two bile acids have complementary effects on biliary lipid metabolism and cholesterol solubilization.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0269-2813
|
pubmed:author |
pubmed-author:AlvisiVV,
pubmed-author:FracchiaMM,
pubmed-author:GalatolaGG,
pubmed-author:HeatonK WKW,
pubmed-author:JazrawiR PRP,
pubmed-author:LanziniAA,
pubmed-author:NorthfieldT CTC,
pubmed-author:PazziPP,
pubmed-author:PetroniM LML,
pubmed-author:PigozziM GMG,
pubmed-author:PoddiEE,
pubmed-author:ZuinMM
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
123-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11136285-Adult,
pubmed-meshheading:11136285-Chenodeoxycholic Acid,
pubmed-meshheading:11136285-Cholelithiasis,
pubmed-meshheading:11136285-Cholesterol,
pubmed-meshheading:11136285-Drug Therapy, Combination,
pubmed-meshheading:11136285-Female,
pubmed-meshheading:11136285-Humans,
pubmed-meshheading:11136285-Male,
pubmed-meshheading:11136285-Middle Aged,
pubmed-meshheading:11136285-Solubility,
pubmed-meshheading:11136285-Ursodeoxycholic Acid
|
pubmed:year |
2001
|
pubmed:articleTitle |
Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.
|
pubmed:affiliation |
St. George's Hospital, London, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|